Document:

REGISTRATION RIGHTS AGREEMENT

         This Registration Rights Agreement (this "Agreement") is by and between
TRINITY  MEDICAL GROUP USA, INC., a Florida  Corporation  (the  "Company"),  and
___________________________ (the "Holder") dated as of this _____ day of ______,
2000.

                              W I T N E S S E T H:

         WHEREAS,  the  Company  has  issued  100  shares  of  company  Series A
Preferred Stock, no par value (collectively "the Units"), each share of Series A
Preferred  Stock is convertible  at the Company's  option to 10 shares of common
stock,  par value  $0.01,  and a  non-callable  common  stock  purchase  warrant
("Warrant"), designated "A Warrants" purchased pursuant to the Private Placement
Memorandum, dated June __, 2000; and

         WHEREAS,   the  Company   desires  to  grant  to  the  Holder   certain
registration  rights in  respect  of the  issuance  or  resale  of the  Series A
Preferred Shares.

         NOW,  THEREFORE,  in  consideration  of the  premises  and  the  mutual
covenants  contained  herein,  and other good and  valuable  consideration,  the
receipt and  sufficiency  of which is hereby  acknowledged,  the parties  hereto
agree as follows:

                                   ARTICLE ONE

                          Registration Rights Agreement

         SECTION  1.1  Registration  Rights  Available.  The  Company  agrees to
provide Holder with respect to the shares of Series A Preferred Shares, pursuant
to the  Private  Placement  Memorandum,  dated  June  21,  2000  and  any  other
securities issued or issuable at any time or from time to time in respect of the
shares  of  Series  A  Preferred  Shares  upon a stock  split,  stock  dividend,
recapitalization or other similar event involving the Company (collectively, the
"Securities"):  one demand secondary offering by means registration  pursuant to
the  Securities  Act of 1933,  as  amended  ("Securities  Act"),  subject to the
provisions  of this  Agreement  (the  demand  registration  right is referred to
herein as the "Registration Right").

         SECTION 1.2 Demand Registration.  With respect to Holder's right to one
demand registration pursuant to Section 1.1 (a), the parties agree as follows:

         (a) The  Company  shall  promptly,  and in any event  within 90 days of
receiving  notice  from the  Holders,  use its  best  efforts  to file  with the
Securities  and  Exchange  Commission  (the  "Commission")  and  cause to become
effective,  a registration  statement on appropriate  form relating to the offer
and sale of the Series A Preferred  Shares by Holder.  The Company shall use its
best efforts to file a registration  statement for the demand secondary offering
requested under Section 1.1. The Company agrees to provide Holder with notice of
the  filing  of  such  registration  and of the  filing  of  any  amendments  or
supplements thereto.

         (b) The  Company  agrees to maintain  such  registration  statement  in
effect for the maximum period allowable under the regulations promulgated by the
Commission then in effect.

         (c) In any offering  pursuant to this Section that becomes effective in
which the Holder  participates,  the Company  shall use its best efforts to keep
available  to the  Holder a  prospectus  meeting  the  requirements  of  Section
10(a)(3) of the Securities  Act and shall file all  amendments  and  supplements
under the Securities Act required for that purpose.  In any offering pursuant to
this Section the Company will, as soon as  practicable,  use its best efforts to
effect such  registration and use its best efforts to effect such  qualification
and  compliance  as may be so requested  and as would permit or  facilitate  the
distribution of such Securities,  including,  without  limitation,  registration
under the Securities Act,  appropriate  qualifications under applicable blue-sky
or  other  state  securities

<PAGE>

laws,  appropriate  compliance  with any  other  governmental  requirements  and
listing  on a national  securities  exchange  on which the Common  Stock is then
listed or inter-dealer quotation system.

         SECTION 1.3 Registration  Procedures.  With respect to the Registration
Right, the following provisions shall apply:

         (a)  Holder  shall be  obligated  to  furnish  to the  Company  and the
underwriters (if any) such information regarding the Securities and the proposed
manner of distribution of the Securities as the Company and the underwriters (if
any) may  request in writing and as shall be  required  in  connection  with any
registration, qualification or compliance referred to herein and shall otherwise
cooperate with the Company and the underwriters (if any) in connection with such
registration, qualification or compliance.

         (b) With a view to making  available  the benefits of certain rules and
regulations  of the  Commission  which  may at any time  permit  the sale of the
Restricted  Securities  (used herein as defined in Rule 144 under the Securities
Act) to the public  without  registration,  the  Company  agrees to use its best
lawful efforts to:

                  (i) Make and keep public information available, as those terms
         are understood and defined in Rule 144 under the Securities Act, at all
         times during which the Company is subject to the reporting requirements
         of the  Securities  Exchange  Act of 1934,  as amended  (the  "Exchange
         Act");

                  (ii) File with the  Commission  in a timely manner all reports
         and other  documents  required of the Company under the  Securities Act
         and the  Exchange Act (at all times during which the Company is subject
         to such reporting requirements); and

                  (iii) So long as Holder  owns any  Restricted  Securities,  to
         furnish to Holder  forthwith  upon  request a written  statement by the
         Company as to its compliance  with the reporting  requirements  of said
         Rule 144 and with regard to the Securities Act and the Exchange Act (at
         all times  during  which  the  Company  is  subject  to such  reporting
         requirements),  a copy of the most recent annual or quarterly report of
         the Company,  and such other  reports and  documents of the Company and
         other information in the possession of or reasonably  obtainable by the
         Company as Holder may reasonably request in availing  themselves of any
         rule or regulation of the Commission  allowing  Holder to sell any such
         securities without registration.

         (c) The Company  agrees  that it will  furnish to Holder such number of
prospectuses,   offering   circulars   or  other   documents   incident  to  any
registration,  qualification or compliance referred to herein as provided or, if
not otherwise provided, as the Holder from time to time may reasonably request.

         (d) Except for the legal fees of Holder and any sales  commissions that
may be paid by Holder,  all expenses of any registrations  permitted pursuant to
this  Agreement and of all other  offerings by the Company  (including,  but not
limited to, the expenses of any qualifications under the blue-sky or other state
securities laws and compliance with  governmental  requirements of preparing and
filing any post-effective amendments required for the lawful distribution of the
Securities  to the public in  connection  with such  registration,  of supplying
prospectuses,  offering  circulars  or  other  documents)  will  be  paid by the
Company.

         (e) The Registration Right of this Agreement,  subject to the terms and
conditions hereof, shall be available to any subsequent holder of the Securities
owned by Holder. Each subsequent holder entitled to the Registration Right under
this  Agreement  shall be bound by the terms and subject to the  obligations  of
this Agreement as though it were an original signatory hereto.

                                   ARTICLE TWO
                                 Indemnification

         SECTION  2.1  Indemnification  by  the  Company.  In the  event  of any
registration  of the  Securities  of the Company under the  Securities  Act, the
Company  agrees to indemnity and hold harmless  Holder and each other person who
participates  as an  underwriter  in the  offering  or sale  of such  securities
against any and all  claims,  demands,  losses,  costs,  expenses,  obligations,
liabilities,  joint or several, damages, recoveries and deficiencies,  including
interest,  penalties and  attorneys'  fees  (collectively,  "Claims"),  to which
Holder or underwriter  may

                                      -2-
<PAGE>

become subject under the Securities Act or otherwise, insofar as such Claims (or
actions or proceedings,  whether  commenced or threatened,  in respect  thereof)
arise out of or are based on any untrue statement or alleged untrue statement of
any material fact contained in any  registration  statement under which Holder's
Securities were registered under the Securities Act, any preliminary prospectus,
final prospectus or summary prospectus  contained  therein,  or any amendment or
supplement  thereto,  or any  omission or alleged  omission  to state  therein a
material fact required to be stated  therein or necessary to make the statements
therein not  misleading,  and the Company  will  reimburse  Holder and each such
underwriter for any legal or any other expenses  reasonably  incurred by them in
connection  with  investigating  or  defending  any such  Claim  (or  action  or
proceeding in respect thereof); provided that the Company shall not be liable in
any such case to the  extent  that any such Claim (or  action or  proceeding  in
respect  thereof) or expense arises out of or is based on an untrue statement or
alleged  untrue   statement  or  omission  or  alleged  omission  made  in  such
registration  statement,  any such  preliminary  prospectus,  final  prospectus,
summary  prospectus,  amendment or  supplement  in reliance on and in conformity
with written  information  furnished to the Company  through an instrument  duly
executed by Holder  specifically  stating that it is for use in the  preparation
thereof.  Such indemnity shall remain in full force and effect regardless of any
investigation  made by or on behalf of Holder or any such  underwriter and shall
survive the transfer of the Securities by Holder.

         SECTION 2.2  Indemnification by Holder.  The Company may require,  as a
condition  to including  the  Securities  in any  registration  statement  filed
pursuant to this Agreement,  that the Company shall have received an undertaking
satisfactory  to it from  Holder,  to indemnify  and hold  harmless (in the same
manner and to the same  extent as set forth in Section  2.1) the  Company,  each
director of the Company,  each officer of the Company and each other person,  if
any, who controls the Company,  within the meaning of the  Securities  Act, with
respect to any statement or alleged statement in or omission or alleged omission
from such registration statement,  any preliminary prospectus contained therein,
or any amendment or supplement  thereto,  if such statement or alleged statement
or omission or alleged  omission was made in reliance on and in conformity  with
written information furnished to the Company through an instrument duly executed
by Holder  specifically  stating that it is for use in the  preparation  of such
registration  statement,   preliminary  prospectus,  final  prospectus,  summary
prospectus, amendment or supplement.  Notwithstanding the foregoing, the maximum
liability  hereunder  which any  holder  shall be  required  to suffer  shall be
limited to the net  proceeds  to such Holder  from the  Securities  sold by such
Holder in the offering.  Such  indemnity  shall remain in full force and effect,
regardless of any investigation  made by or on behalf of the Company or any such
director,  officer or  controlling  person and shall survive the transfer of the
Securities by Holder.

         SECTION  2.3  Notices  of Claims,  etc.  Promptly  after  receipt by an
indemnified  party of notice of the  commencement  of any  action or  proceeding
involving a Claim referred to in this Article Two, such indemnified  party will,
if a claim in respect thereof is to be made against an indemnifying  party, give
written notice to the latter of the  commencement of such action,  provided that
the failure of any indemnified party to give notice as provided herein shall not
relieve the indemnifying party of its obligations under this Article Two, except
to the extent that the indemnifying party is actually prejudiced by such failure
to give  notice.  In case any such  action is brought  against  an  indemnifying
party,  unless in such  indemnified  party's  reasonable  judgment a conflict of
interest between such indemnified and indemnifying  parties may exist in respect
of such Claim, the indemnifying party shall be entitled to participate in and to
assume the defense thereof,  jointly with any other indemnifying party similarly
notified to the extent that it may wish, with counsel reasonably satisfactory to
such indemnified  party,  and after notice from the  indemnifying  party to such
indemnified  party  of its  election  so to  assume  the  defense  thereof,  the
indemnifying  party shall not be liable to such indemnified  party for any legal
or other  expenses  subsequently  incurred by the latter in connection  with the
defense thereof other than reasonable  costs of  investigation.  No indemnifying
party shall,  without the consent of the indemnified party,  consent to entry of
any  judgment  or  enter  into  any  settlement  that  does  not  include  as an
unconditional  term  thereof  the giving by the  claimant or  plaintiff  to such
indemnified party of a release from all liability in respect of such Claim.

         SECTION 2.4 Indemnification  Payments. The indemnification  required by
this Article shall be made by periodic payments of the amount thereof during the
course of the  investigation  or  defense,  as and when  bills are  received  or
expense, loss, damage or liability is incurred.

                                      -3-

<PAGE>

                                  ARTICLE THREE
                                  Miscellaneous

         SECTION  3.1  Consent  to  Amendments.  Except as  otherwise  expressly
provided herein,  the provisions of this Agreement may be amended or waived only
by the  written  agreement  of the  Company and the Holder of 51% or more of the
shares of Common  Stock and shall be effective  only to the extent  specifically
set forth in such writing.

         SECTION 3.2 Term of the Agreement.  This Agreement shall terminate with
respect to Holder on the  earlier  to occur of (i) the  Securities  having  been
registered as provided in Article One or (ii) September 15, 2000.

         SECTION 3.3  Successors  and  Assigns.  Except as  otherwise  expressly
provided herein, all covenants and agreements  contained in this Agreement by or
on behalf of any of the parties hereto are  transferable and will bind and inure
to the benefit of the respective  successors and assigns of the parties  hereto,
but only if so expressed in writing.

         SECTION 3.4  Severability.  Whenever  possible,  each provision of this
Agreement  will be  interpreted  in such a manner as to be  effective  and valid
under  applicable  law,  but if any  provision  of this  Agreement is held to be
prohibited  by  or  invalid  under   applicable  law,  such  provision  will  be
ineffective  only to the  extent  of such  prohibition  or  invalidity,  without
invalidating the remainder of this Agreement.

         SECTION 3.5 Delays or Omissions. No failure to exercise or delay in the
exercise  of any  right,  power or remedy  accruing  to Holder on any  breach or
default of the Company under this Agreement  shall impair any such right,  power
or  remedy  nor  shall it be  construed  to be a waiver  of any such  breach  or
default.

         SECTION 3.6 Remedies Cumulative.  All remedies under this Agreement, or
by law or otherwise  afforded to any party hereto  shall be  cumulative  and not
alternative.

         SECTION 3.7  Descriptive  Headings.  The  descriptive  headings of this
Agreement are inserted for convenience only and do not constitute a part of this
Agreement.  Unless  clearly  denoted  otherwise,  any  reference  to Articles or
Sections  contained  herein  shall  be to  the  Articles  or  Sections  of  this
Agreement.

         SECTION 3.8  Notices.  Any notices  required  or  permitted  to be sent
hereunder  shall be  delivered  personally  or mailed,  certified  mail,  return
receipt requested, to the following addresses,  and shall be deemed to have been
received on the day of personal  delivery or within  three  business  days after
deposit in the mail, postage prepaid:

         If to the Company, to:
                                            James Namnath
                                            Trinity Medical Group USA, Inc.
                                            55 Shaver Street
                                            Suite 320
                                            San Rafael, CA 94901
                  If to Holder, to:
                  -------------------------------
                  -------------------------------
                  -------------------------------

         SECTION 3.9  Governing  Law. The  validity,  meaning and effect of this
Agreement shall be determined in accordance with the laws of the State of Nevada
applicable to contracts made and to be performed in that state.

         SECTION  3.10 Final  Agreement.  This  Agreement,  together  with those
documents  expressly referred to herein,  constitutes the final agreement of the
parties  concerning  the matters  referred to herein,  and  supersedes all prior
agreements and understandings.

                                      -4-
<PAGE>

         SECTION 3.11 Execution in Counterparts.  This Agreement may be executed
in any number of  counterparts,  each of which when so  executed  and  delivered
shall be deemed an original, and such counterparts together shall constitute one
instrument.

         The parties  hereto have executed  this  Agreement as of the date first
set forth above.

TRINITY MEDICAL GROUP USA, INC.

By: /s/ James Namnath                     Title  Chief Executive Officer
   ---------------------------------           ---------------------------------
        James Namnath, Ph.D.

Witness by: /s/ Elizabeth Namnath         Title Secretary
           --------------------------------    ---------------------------------
         Elizabeth Namnath

                                      -5-THE SALE AND ISSUANCE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT
BEEN  REGISTERED  UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE  "SECURITIES
ACT"), OR UNDER THE SECURITIES LAW OF ANY STATE OR OTHER  JURISDICTION.  NEITHER
THIS  SECURITY NOR ANY INTEREST OR  PARTICIPATION  HEREIN MAY BE OFFERED,  SOLD,
ASSIGNED, TRANSFERRED,  PLEDGED, ENCUMBERED,  HYPOTHECATED OR OTHERWISE DISPOSED
OF, UNLESS PURSUANT TO AN EFFECTIVE  REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO A  TRANSACTION  THAT IS EXEMPT FROM,  OR NOT SUBJECT TO, SUCH
REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS.

                     TRINITY MEDICAL MEDICAL GROUP USA, INC.

                          COMMON STOCK PURCHASE WARRANT

         1. Issuance. In consideration of good and valuable  consideration,  the
receipt of which is hereby  acknowledged  by Trinity  Medical Group USA, Inc., a
Florida  corporation (the "Company"),  [[_____________]],  or registered assigns
(the  "Holder")  is hereby  granted the right to purchase at any time until 5:00
P.M.,  New  York  City  time,  on  July  24,  2002  (the   "Expiration   Date"),
_____________(__________)  fully paid and nonassessable  shares of the Company's
Common  Stock,  par value  $.001 per share  (the  "Common  Stock") at an initial
exercise  price of $4.00 per share (the  "Exercise  Price"),  subject to further
adjustment as set forth in Section 6 hereof.

         2.  Exercise of Warrants.  This Warrant is  exercisable  in whole or in
part at the Exercise Price per share of Common Stock payable hereunder,  payable
in cash or by certified or official bank check.  Upon  surrender of this Warrant
Certificate  with the annexed  Notice of Exercise Form duly  executed,  together
with payment of the Exercise Price for the shares of Common Stock purchased, the
Holder shall be entitled to receive a certificate or certificates for the shares
of Common Stock so purchased.

         3.  Reservation of Shares.  The Company hereby agrees that at all times
during the term of this  Warrant  there  shall be  reserved  for  issuance  upon
exercise of this  Warrant  such number of shares of its Common Stock as shall be
required for issuance upon exercise of this Warrant (the "Warrant Shares").

         4.  Mutilation  or Loss of  Warrant.  Upon  receipt  by the  Company of
evidence  satisfactory  to it of the loss,  theft,  destruction or mutilation of
this  Warrant,  and (in the  case of  loss,  theft or  destruction)  receipt  of
reasonably  satisfactory  indemnification,  and (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will execute and

<PAGE>

deliver  a new  Warrant  of like  tenor  and  date and any  such  lost,  stolen,
destroyed or mutilated Warrant shall thereupon become void.

         5. Rights of the Holder.  The Holder  shall not, by virtue  hereof,  be
entitled to any rights of a stockholder in the Company, either at law or equity,
and the rights of the Holder are limited to those  expressed in this Warrant and
are not enforceable against the Company except to the extent set forth herein.

         6. Protection Against Dilution.

            6.1 Adjustment Mechanism.  If an adjustment of the Exercise Price is
required  pursuant to this  Section 6, the Holder  shall be entitled to purchase
such  number of  additional  shares of Common  Stock as will cause (i) the total
number of shares of Common Stock Holder is entitled to purchase pursuant to this
Warrant,  multiplied  by (ii) the adjusted  purchase  price per share,  to equal
(iii) the dollar  amount of the total number of shares of Common Stock Holder is
entitled to purchase  before  adjustment  multiplied by the total purchase price
before adjustment.

            6.2 Capital Adjustments. In case of any stock split or reverse stock
split, stock dividend,  reclassification of the Common Stock,  recapitalization,
merger or consolidation,  or like capital adjustment  affecting the Common Stock
of the  Company,  the  provisions  of this Section 6 shall be applied as if such
capital  adjustment  event had  occurred  immediately  prior to the date of this
Warrant and the original  purchase price had been fairly  allocated to the stock
resulting from such capital adjustment;  and in other respects the provisions of
this Section shall be applied in a fair,  equitable and reasonable  manner so as
to give effect,  as nearly as may be, to the purposes  hereof. A rights offering
to  stockholders  shall be deemed a stock  dividend to the extent of the bargain
purchase element of the rights.

         7. Transfer to Comply with the Securities Act; Registration Rights.

         (1) This Warrant has not been  registered  under the  Securities Act of
1933, as amended,  (the "Act") and has been issued to the Holder for  investment
and not with a view to the  distribution  of either the  Warrant or the  Warrant
Shares. Neither this Warrant nor any of the Warrant Shares or any other security
issued or  issuable  upon  exercise of this  Warrant  may be sold,  transferred,
pledged or  hypothecated in the absence of an effective  registration  statement
under the Act relating to such security or an opinion of counsel satisfactory to
the Company that  registration  is not required under the Act. Each  certificate
for the Warrant,  the Warrant Shares and any other  security  issued or issuable
upon exercise of this Warrant  shall  contain a legend on the face  thereof,  in
form and substance  satisfactory  to counsel for the Company,  setting forth the
restrictions on transfer contained in this Section.

                                       2
<PAGE>

         (2) The  Company  hereby  grants to the Holder  piggyback  registration
rights with respect to the Warrant Shares.  In the event the Company is filing a
Registration  Statement for itself or on behalf of any of its shareholders,  the
Company shall notify the Holder in writing  reasonably in advance of such filing
(but at least five business days) and give the Holder the opportunity to include
all or any party of the Warrant Shares (whether or not previously issued, to the
extent permissible under the Act or any regulation promulgated thereunder). Upon
the Holder's  notification that the Holder desires to have all or any portion of
the Warrant Shares included in such registration,  the Company shall, at no cost
or expense to the Holder,  include or cause to be included in such  registration
statement the Warrant Shares so identified by the Holder.

         (3) In addition to the registration rights referred to in the preceding
provisions of Section (b),  effective after the expiration of the  effectiveness
of the Registration  Statement as contemplated by this Warrant, the Holder shall
have demand  piggy-back  registration  rights with respect to the Warrant Shares
then held by the  Holder or then  subject  to  issuance  upon  exercise  of this
Warrant  (collectively,   the  "Remaining  Warrant  Shares"),   subject  to  the
conditions set forth below. If, at any time after the Registration Statement has
ceased to be effective,  the Company  participates  (whether  voluntarily  or by
reason of an obligation to a third party) in the  registration  of any shares of
the Company's stock, the Company shall give written notice thereof to the Holder
and the Holder shall have the right,  exercisable  within ten (10) business days
after  receipt of such  notice,  to demand  inclusion of all or a portion of the
Holder's Remaining Warrant Shares in such registration statement.

         8.  Notices.  Any notice or other  communication  required or permitted
hereunder  shall be in writing and shall be delivered  personally,  telegraphed,
telexed,  sent by facsimile  transmission  or sent by  certified,  registered or
express mail,  postage  pre-paid.  Any such notice shall be deemed given when so
delivered personally,  telegraphed,  telexed or sent by facsimile  transmission,
or, if mailed, two days after the date of deposit in the United States mails, as
follows:

                  (1) if to the Company, to:

                  Trinity  Medical  Group  USA,  Inc. .
                  55 Shaver St.
                  San Rafael, CA  94901
                  Attn: Chief Executive Officer

                  (2) if to the Holder, to:

                  [[                ]]

                                       3
<PAGE>

Any party may be  notice  given in  accordance  with this  Section  to the other
parties designate another address or person for receipt of notices hereunder.

         9.  Supplements and Amendments;  Whole  Agreement.  This Warrant may be
amended or  supplemented  only by an instrument in writing signed by the parties
hereto. This Warrant of even date herewith contain the full understanding of the
parties  hereto with respect to the subject  matter hereof and thereof and there
are no  representations,  warranties,  agreements or  understandings  other than
expressly contained herein and therein.

         10.  Governing  Law. This Warrant shall be deemed to be a contract made
under  the laws of the  State  of [[New  York]]  and for all  purposes  shall be
governed by and construed in accordance  with the laws of such State  applicable
to contracts to be made and performed entirely within such State.

         11.  Counterparts.  This  Warrant  may be  executed  in any  number  of
counterparts and each of such  counterparts  shall for all purposes be deemed to
be an original,  and all such counterparts shall together constitute but one and
the same instrument.

         12. Descriptive Headings.  Descriptive headings of the several Sections
of this  Warrant  are  inserted  for  convenience  only and shall not control or
affect the meaning or construction of any of the provisions hereof.

         IN WITNESS WHEREOF, the parties hereto have executed this Warrant as of
the __th day of ______ __, 2000.

                                                 TRINITY MEDICAL GROUP USA, INC.

                                                 By:
                                                    ----------------------------
                                                    Name: ______________________
                                                    Title: _____________________

Attest:

----------------------------
----------------------------

                                       4
<PAGE>

                          NOTICE OF EXERCISE OF WARRANT

         The  undersigned  hereby  irrevocably  elects to  exercise  the  right,
represented by the Warrant Certificate dated as of __________, 2000, to purchase
__________  shares of the Common Stock,  par value $______ per share, of Trinity
Medical Group USA, Inc. and tenders  herewith payment in accordance with Section
1 of said Common Stock Purchase Warrant.

         Please deliver the stock certificate to:

Dated:______________________

                                  By:
                                     ----------
                                  ------------------------

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}]]